Hence, we sought to describe the EGFR activation in our 10 tumor lines, studying the expression of phosphorylated EGFR (phospho-EGFR) and downstream signaling proteins (phospho-AKT and phospho-MEK1). This evidence concerns the gene EGFR and neoplasm.